Discover OMA's JOMOO Headquarters in Xiamen, an architectural landmark blending urban and natural landscapes for China's top ...

Meta’s embrace of AMD’s MI300X makes AMD the prime second source to Nvidia as AI compute demand accelerates. Read why I rate ...

Imagine a liquid that flows freely one moment, then stiffens into a near-solid the next, and then can switch back with a ...

A professional greenkeeper has revealed the simple method that will make your lawn thicker and greener, used by groundkeepers ...

Recent progress in the field of robotic manipulation has generated interest in fully automatic object packing in warehouses. This article presents a formulation of the robotic packing problem that ...

1. Having dense breasts increases your risk of breast cancer. Why it matters: Not only is the risk higher, but it’s also harder to detect cancer in dense breasts.

Irregular Periods? Read on to know what your missed or delayed menstrual cycle could really say about your inner health – From PCOS to thyroid issues, check all the hidden causes behind menses ...

Designing a new class of functional materials is heavily dependent on the fundamental understanding of the crystallization mechanism and the effect of physicochemical parameters. The rational design ...

Signs of Cancerous Masses Cancerous masses in the breast are often very firm, like a rock. They have an irregular shape and size. They can be mobile but are often fixed, meaning they feel like they ...

Seed cycling is a growing social media trend that claims to balance hormones, fix irregular periods, boost fertility and reduce PCOS symptoms. As PCOS, irregular periods and hormonal imbalance ...

It also contributes to oxidative stress in the atria – the heart’s upper chambers – altering their size, shape, and function. This cardiac remodeling is a key driver of irregular heart rhythms.

At 12-year follow-up, C9741 confirmed the sustained long-term benefit of adjuvant dose-dense chemotherapy for node-positive breast cancer. SET2,3 identified patients with ER+ breast cancer who ...